Dan Olmstead
About Dan Olmstead
Dan Olmstead serves as the Vice President of Market Access at Ardelyx, Inc., where he leads a team of 31 professionals and has developed a comprehensive market access strategy for the company's pipeline assets. He has a strong background in managing reimbursement strategies and specializes in various medical fields, including nephrology and orthopedics.
Work at Ardelyx
Dan Olmstead has served as Vice President of Market Access at Ardelyx, Inc. since 2019. In this role, he leads a team of 31 professionals across various functions, including payer accounts, trade/distribution, and dialysis provider organizations. He has developed a comprehensive U.S. market access strategy for Ardelyx's pipeline assets, emphasizing distribution and patient services. His leadership contributes to the company's efforts in enhancing market access for its products.
Previous Experience at Genzyme
Prior to his current position, Dan Olmstead worked at Genzyme for eight years. He held the role of Senior Corporate Account Director from 2005 to 2010 and later served as Senior Director of Corporate Accounts from 2010 to 2013. During his tenure, he focused on managing corporate accounts and developing strategies to enhance market access for Genzyme's products.
Experience at Walgreens
Dan Olmstead was employed at Walgreens as National Accounts Director for 11 months in 2013. In this position, he was responsible for managing national accounts, contributing to the company's strategic initiatives in market access.
Education and Expertise
Dan Olmstead studied at the University of Michigan, where he earned a Bachelor of General Studies (BGS) from 1981 to 1985. He specializes in nephrology, orthopedics, ophthalmology, diabetes, and infectious diseases, with a focus on market access and reimbursement strategies. His expertise includes managing reimbursement strategies with large national health plans, particularly in the context of rare diseases and orphan drugs.
Achievements in Pharmaceutical Launches
Dan Olmstead has a proven track record in launching new pharmaceutical and medical device products. His experience emphasizes strategic planning and sales management, which are critical components in successfully bringing products to market.